Impact of obesity in primary hyperlipidemias

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 11, Issue 5, 2001, Pages 354-359

  Carmena, R ^a,b   Ascaso, J F ^a   Real, J T ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Familial combined hyperlipidemia; Hyperlipidemia; Insulin resistance; Obesity

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; BLOOD; BODY CONSTITUTION; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL HYPERLIPEMIA; FEMALE; HISTOLOGY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW;

ADIPOSE TISSUE; APOLIPOPROTEINS B; BODY CONSTITUTION; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; TRIGLYCERIDES;

EID: 0035495492     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Després JP (1994) Dyslipidemia and obesity. Baillières Clin Endocrinol Metab 8: 629-660
2. Lean MEJ (1999) Obesity and eating disorders. In: Betteridge DJ, Illingworth DR, Shepherd J (Eds) Lipoproteins in Health and Disease. Arnold, London, pp 881-895
3. Denke MA, Sempos CT, Grundy SM (1994) Excess body weight: an under-recognised contributor to dyslipidemia in white American women. Arch Intern Med 154: 401-410
4. Schulte P, Cullen P, Assmann G (1999) Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis 144: 199-209
5. Björntorp P (1994) Fatty acids, hyperinsulinemia, and insulin resistance: which comes first?. Curr Opin Lipidol 5: 166-174
6. Laakso M, Pyorälä K, Voutilainen E, Marniemi J (1987) Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 416-422
7. Cambien F, Warner JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G (1987) Body mass index, blood pressure, glucose and lipids: does plasma insulin explain their relationship? Arteriosclerosis 7: 197-202
8. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422
9. Karhapaa P, Voutilainen E, Kovanen PT, Laakso M (1993) Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscler Thromb 13: 41-47
10. Salomaa VV, Tuomilehto J, Jauhiainen M, Korhonen HJ, Stengard J, Uusitupa M, Pitkanen M, Penttila I (1992) Hypertrigliceridemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 15: 657-665
11. Mostaza JM, Vega GL, Snell P, Grundy SM (1998) Abnormal metabolism of free fatty acids in hypertriglyceridemic men: apparent insulin resistance of adipose tissue. J Intern Med 243: 265-274
12. Carmena R, Ascaso JF, Tebar J, Soriano J (1984) Changes in plasma high-density lipoproteins after body weight reduction in obese women. Int J Obes 8: 135-140
13. Arner P (1997) Is familial combined hyperlipidemia a genetic disorder of adipose tissue? Curr Opin Lipidol 8: 89-94
14. Wojciechowski AP, Farrall M, Cullen P, Wilson TM, Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ, Shepherd J, et al (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature 349: 161-164
15. Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB (1983). Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24: 147-155
16. Ascaso JF, Serrano S, Martínez-Valls J, Hernández A, DeLera, Carmena R (1992) Plasma lipoproteins in familial combined hyperlipidemia: a study of hyperlipemic and normolipidemic kindreds. Nutr Metab Cardiovasc Dis 2: 165-169
17. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J (1993) Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 13: 1110-1118
18. Janus ED, Nicoll A, Turner PR, Magill PJ, Lewis B (1980) Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 10: 161-171
19. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR (1989) Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9: 335-344
20. Castro-Cabezas M, de Bruin TWA, de Valk HW, Shoulders CC, Jansen H, Erkelens EW (1993) Impaired fatty acid metabolism in familial combined hyperlipidemia: a mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 92: 160-168
21. Ascaso JF, Merchante A, Lorente R, Real JT, Martínez-Valls J, Carmena R (1998) A study of insulin resistance using minimal model in nondiabetic familial combined hyperlipidemic patients. Metabolism 47: 508-513
22. Hollenbeck CB, Reaven G (1987). Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169-1173
23. Romero P, Real JT, Priego A, Valdecabres C, Ascaso JF, Carmena R (2001) Cuantificacíon de insulinorresistencia con los valores de insulina basal e índice HOMA en la población general. Med Clin
24. Krotkiewski M, Björntorp P, Sjostrom L, Smith U (1983) Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 72: 1150-1162
25. Bergstrom RW, Newel-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WJ (1990) Association of elevated fasting c-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39: 104-111
26. Bergstrom RW, Leonetti DL, Newel-Morris LL, Shuman WP, Wahl PW, Fujimoto WJ (1990) Association of plasma triglyceride and c-peptide with coronary heart disease in Japanese-American men with high prevalence of glucose intolerance. Diabetologia 33: 489-496
27. Blair D, Habricht JP, Sims EAH, Sylvester D, Abraham S (1984) Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 119: 526-540
28. Real JT, Ascaso JF, Carmena R (1999) Insulin resistance and familial combined hyperlipidemia. Cardiovas Risk Factors 9: 101-106
29. Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martínez-Valls J, Carmena R (1997) Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia. Int J Obes Relat Metab Disord 21: 360-366
30. Bredie SJH, Tack CJJ, Smits P, Stalenhoef AFH (1997) Non-obese patients with familial combined are insulin resistant as compared with their non-affected relatives. Arterioscler Thromb Vase Biol 17: 1465-1471
31. Frayn KN (1993) Insulin resistance and lipid metabolism. Curr Opin Lipidol 4: 197-204
32. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk MJ, Potts JL, Hockaday TDR (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264-272
33. Barlett SM, Gibbons GF (1988) Short- and longer-term regulation of very low density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J 249: 37-43
34. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 41: 715-722
35. Mykkanen L, Kuusisto J, Haffner SM, Pyorälä K, Laakso M (1994) Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 14: 518-526
36. Cianflone K, Maslowska M, Sniderman AD (1990) Impaired response to fibroblasts in patients with hyperapobetalipoproteinemia to acylation stimulating protein. J Clin Invest 85: 722-730
37. Arner P, Engfeldt P, Östman J (1992) Changes in the metabolism of fatty acids in adipose tissue in obese patients with primary hypertriacylglycerolemia. J Lipid Res 23: 422-427
38. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD (1994) The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33: 9489-9495
39. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789
40. Steiner G, Vranic M (1982) Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Int J Obes 6 (suppl 1): 117-124
41. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL (1976) Myocardial infarction in the familial forms of Hypertriglyceridemia. Metabolism 25: 313-320
42. Ascaso JF, Lorente R, Merchante A, Real JT, Priego A, Carmena R (1997) Insulin resistance in patients with familial combined hyperlipidemia and coronary heart disease. Am J Cardiol 80: 1484-1487
43. Després JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957
44. Tzagournis M, Chiles R, Ryan JM, Skillman TG (1968) Interrelationship of hyperinsulinism and hypertrygliceridemia in young patients with coronary heart disease. Circulation 38: 1156-1163